Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
Publications
2 shownNivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 6,169
- Institution
- Hospital Universitario 12 De Octubre
External Links
Identifiers
- ORCID
- 0000-0002-9106-0687
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.